Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

AACR 2017 /
Nivolumab and ipilimumab combination for advanced skin cancer

1st - 5th Apr 2017

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 12.04.17
Views: 2057

Dr James Larkin - The Royal Marsden, London, UK

Dr Larkin presents results from Checkpoint 067, a trail of combined nivolumab and ipilimumab for advanced melanoma, at AACR 2017.

Slides from this presentation are available here, and you can read more about the results here.

Dr Suzanne Topalian spoke with ecancer about these results here.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation